Medicofarma Biotech Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0	0.01	0.01	0.51	0.08
Cash & Short-Term Investments	0	0.01	0.01	0.51	0.08
Cash Growth	-72.08%	19.22%	-98.97%	556.50%	20.91%
Accounts Receivable	1.45	0.48	0.38	0.37	1.42
Other Receivables	3.67	3.33	2.13	1.24	0.03
Receivables	5.11	3.8	2.51	1.61	1.45
Inventory	-	0	0	0.14	0.56
Total Current Assets	5.11	3.81	2.52	2.26	2.08
Property, Plant & Equipment	9.03	10.55	12.09	12.56	12.7
Other Intangible Assets	0.05	0.1	0.15	1.54	1.98
Long-Term Deferred Tax Assets	-	0.24	0.21	-	-
Other Long-Term Assets	0.01	0.01	-	0.01	-
Total Assets	14.2	14.71	14.97	16.37	16.77
Accounts Payable	1.22	1.29	1.19	1.34	1.47
Accrued Expenses	0.48	1.56	2.26	1.11	0.44
Short-Term Debt	0	0	0	-	-
Current Income Taxes Payable	2.23	1.5	0.53	0.14	0.06
Other Current Liabilities	0.15	0.13	0.04	0.69	0.12
Total Current Liabilities	4.09	4.49	4.02	3.28	2.08
Long-Term Debt	3.71	2.53	1.39	-	-
Other Long-Term Liabilities	0.72	0.82	0.38	0.48	0.48
Total Liabilities	8.52	7.84	5.8	3.76	2.56
Common Stock	6.8	6.8	6.8	6.8	6.8
Additional Paid-In Capital	8.95	8.95	8.95	8.95	8.95
Retained Earnings	-10.06	-8.87	-6.57	-3.13	-1.54
Shareholders' Equity	5.68	6.87	9.18	12.61	14.2
Total Liabilities & Equity	14.2	14.71	14.97	16.37	16.77
Total Debt	3.71	2.53	1.39	-	-
Net Cash (Debt)	-3.71	-2.53	-1.39	0.51	0.08
Net Cash Growth	-	-	-	556.50%	-
Net Cash Per Share	-0.05	-0.04	-0.02	0.01	0.00
Filing Date Shares Outstanding	67.98	67.98	67.98	67.98	67.98
Total Common Shares Outstanding	67.98	67.98	67.98	67.98	67.98
Working Capital	1.02	-0.68	-1.5	-1.01	-0
Book Value Per Share	0.08	0.10	0.13	0.19	0.21
Tangible Book Value	5.64	6.78	9.02	11.08	12.22
Tangible Book Value Per Share	0.08	0.10	0.13	0.16	0.18
Land	0.52	0.52	0.52	0.52	0.52
Buildings	5.06	5.06	5.06	5.06	5.06
Machinery	9.01	9.01	9.01	8.11	7.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.